Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LIFECORE BIOMEDICAL, INC. \DE\
Report date October 16, 2019 · Filed October 16, 2019
Section 16 reporting ended · disclosed 2019-10-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,117 |
Reported balance
After 2019-10-16 transaction · row 1
1 source rowRow 1 · 2019-10-16 · Grant · Acquired 6,000 · Balance 64,117 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2019-10-16 | Direct | 0 |
Reported balance
After 2019-10-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-10-16 · Exercise / conversion · Disposed 6,000 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on May 30, 2019. F3: Vesting of restricted stock units accelerated on October 16, 2019 by reason of retirement from position on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on May 30, 2019.
F3: Vesting of restricted stock units accelerated on October 16, 2019 by reason of retirement from position on the Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2019 Filed Oct 16, 2019 23:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-012321 · wf-form4_157126963389561.xml · derivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2019. F3 · derivative.exercise_date: Vesting of restricted stock units accelerated on October 16, 2019 by reason of retirement from position on the Board of Directors. F3 · derivative.expiration_date: Vesting of restricted stock units accelerated on October 16, 2019 by reason of retirement from position on the Board of Directors. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 23:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 6,000 | $9.18 | $55,080.00 |
DisclosureSEC source: 0001628280-19-012321 · wf-form4_157126963389561.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,117 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007409 · wf-form4_155926301033884.xml · derivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 30, 2019. F3 · derivative.expiration_date: The restricted stock units vested on May 30, 2019. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $9.91 | $42,018.40 |
DisclosureSEC source: 0001628280-19-007409 · wf-form4_155926301033884.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 28, 2019 Filed May 31, 2019 00:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Units (RSU) · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-007409 · wf-form4_155926301033884.xml · derivative · entry 3 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 18:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001628280-19-002854 · wf-form4_155250263437173.xml · derivative · entry 3 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 18:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,691 | $6.66 | $17,922.06 |
DisclosureSEC source: 0001628280-19-002854 · wf-form4_155250263437173.xml · nonDerivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,877 Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 18:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $6.66 | $33,300.00 |
DisclosureSEC source: 0001628280-19-002854 · wf-form4_155250263437173.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011097 · rdgdoc.xml · derivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010770 · rdgdoc.xml · derivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010770 · rdgdoc.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:11 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001437749-18-004233 · rdgdoc.xml · derivative · entry 3 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:11 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,177 | $13.25 | $28,845.25 |
DisclosureSEC source: 0001437749-18-004233 · rdgdoc.xml · nonDerivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,282 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:11 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.77 | $28,850.00 |
DisclosureSEC source: 0001437749-18-004233 · rdgdoc.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:34 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010676 · rdgdoc.xml · derivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:08 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-010195 · rdgdoc.xml · derivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,282 shares Expires 2017-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2017. F3 · derivative.expiration_date: The restricted stock units vested on May 25, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:08 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,282 | $13.50 | $71,307.00 |
DisclosureSEC source: 0001437749-17-010195 · rdgdoc.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 22, 2017 Filed May 24, 2017 14:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-009958 · rdgdoc.xml · derivative · entry 3 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 24, 2017 14:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,132 | $13.20 | $28,142.40 |
DisclosureSEC source: 0001437749-17-009958 · rdgdoc.xml · nonDerivative · entry 2 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,177 Read SEC document |
| May 22, 2017 Filed May 24, 2017 14:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.63 | $28,150.00 |
DisclosureSEC source: 0001437749-17-009958 · rdgdoc.xml · nonDerivative · entry 1 Tobin Robert · CIK 0001310578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.